Business Parks & Science Centres



Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 54 55 56 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Pieris AG. (10/16/13). "Press Release: Zydus and Pieris Sign Broad Co-development Alliance for Novel Anticalin Therapeutics. c-Met Antagonist, PRS-110, to Be the Flagship Program". Ahmedabad & Freising. 2013-10-16
Sartorius AG. (10/16/13). "Press Release: Sartorius Stedim Biotech and BD Diagnostics Strengthen Cooperation in the Area of Microbiological Diagnostics. Expansion of Product Portfolio for Microbiological Analyses in the Lab". Göttingen & Baltimore, MD. 2013-10-16
AstraZeneca plc. (10/15/13). "Press Release: AstraZeneca Oncology Portfolio Strengthened as MedImmune Acquisition of Spirogen Boosts Antibody-Drug Conjugate Capability. Additional Investment in and Collaboration with ADC Therapeutics". 2013-10-15
Auven Therapeutics Management L.L.L.P.. (10/15/13). "Press Release: Auven Therapeutics Announces AstraZeneca’s MedImmune Acquires Antibody-Drug Conjugate Company Spirogen and Invests in ADC Therapeutics. Both Auven Therapeutics Portfolio Companies". Laus 2013-10-15
Evotec AG. (10/15/13). "Press Release: Evotec Receives Pre-clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2013-10-15
Qiagen GmbH. (10/15/13). "Press Release: Qiagen Launches Empowered Genome Community, Invites Citizen Scientists and Researchers to Pool and Collaboratively Interpret Human Genomes". Redwood City, CA & Hilden. 2013-10-15
Horizon Discovery Ltd.. (10/15/13). "Press Release: Horizon Discovery Receives Share of €5.75M ($7.8M) EU FP7 Grant". Cambridge. 2013-10-15
Immatics Biotechnologies GmbH. (10/15/13). "Press Release: Immatics Closes €34 Million Financing to Complete Phase 3 Development of IMA901 for Renal Cancer". Tübingen. 2013-10-15
BioInvent International AB. (10/14/13). "Press Release: BioInvent and Bayer Extend and Broaden Collaboration for the Discovery and Development of Therapeutic Antibodies". Lund. 2013-10-14
Roche. (10/14/13). "Press Release: Roche to Invest 800 Million Swiss Francs in Global Biologic Medicine Manufacturing Network". Basel. 2013-10-14
Biotest AG. (10/11/13). "Press Release: Biotest AG Opens Three Further Plasmapheresis Centers in Hungary and the USA". Dreieich. 2013-10-11
ImmunoGen, Inc.. (10/11/13). "Press Release: ImmunoGen, Inc. Announces New License Agreement". Waltham, MA. 2013-10-11
Wilex AG. (10/10/13). "Press Release: Wilex Publishes 9-Months Financial Report 2013". Munich. 2013-10-10
Cytos Biotechnology AG. (10/10/13). "Press Release: Cytos Biotechnology Plans Financing of up to CHF 17.6 Million. CHF 9 Million of Proposed Capital Increase Already Firmly Committed by Existing Investors". Schlieren. 2013-10-10
Evotec AG. (10/10/13). "Press Release: Evotec and Harvard University to Collaborate on Exploration of Enteroendocrine Signals Affecting Key Metabolic Pathways". Hamburg. 2013-10-10
Mologen AG. (10/10/13). "Press Release: Mologen AG Completed Planning for Clinical Study with MGN1703 in Small Cell Lung Cancer". 2013-10-10
Heptares Therapeutics Ltd.. (10/10/13). "Press Release: Heptares Delivers First Stabilised GPCR (STaR) to MorphoSys for Antibody Discovery". Welwyn Garden City & Boston, MA. 2013-10-10
Tecan Group Ltd.. (10/9/13). "Press Release: Tecan Maintains Target for Profitability and Adjusts Revenue Guidance for 2013". Männedorf. 2013-10-09
Bayer AG. (10/9/13). "Press Release: RWTH Aachen University and Bayer Found Research Center. Better Understanding of Disease, Faster Developing of Therapies – a Leading European Center for Computer Based Modeling to Be Created". Aachen. 2013-10-09
Ionicon Analytik GmbH. (10/09/13). "Press Release: PTR-TOF Technology Contributes to CLOUD Experiment at CERN. Scientists Publish New Results Concerning Cloud Formulation in »Nature«". Innsbruck. 2013-10-09
Sartorius AG. (10/9/13). "Pressemitteilung: Veröffentlichung einer Stimmrechtsmitteilung [Sartorius AG – Erbengemeinschaft hält 50,09% der Anteile]". 2013-10-09
Sysmex Corporation. (10/9/13). "Press Release: Sysmex Inostics and Bayer HealthCare Collaborate to Develop Blood-based Companion Diagnostic Tests for Targeted Tumor Therapies". 2013-10-09
Curetis AG. (10/9/13). "Press Release: Curetis Presents New Clinical Validation Data on Its Unyvero P50 Pneumonia / LRT Application". Holzgerlingen. 2013-10-09
Bayer AG. (10/8/13). "Press Release: Bayer Accelerates Clinical Development of Promising New Drug Candidates [Not intended for U.S. and UK Media]". Leverkusen. 2013-10-08
MorphoSys AG. (10/7/13). "Press Release: MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (XmAb5574). Extended Treatment Resulted in Higher Overall Response Rate". 2013-10-07
Sartorius Stedim Biotech S.A.. (10/7/13). "Press Release: Sartorius Stedim Biotech Announces Offer to Acquire UK Company TAP Biosystems Group plc. Sartorius Stedim Biotech to Further Expand Its Portfolio of Single-use Fermentors". Aubagne. 2013-10-07
Debiopharm S.A.. (10/7/13). "Press Release: Experimental Therapeutics Centre and Debiopharm Group to Collaborate for the Development of an Epigenetic Innovative Oncology Target". Singapore & Lausanne. 2013-10-07
Sony DADC. (10/7/13). "Press Release: Sony DADC and Schott Develop Glass-plastic Hybrid Cell Imaging Slide". Salzburg & Jena. 2013-10-07
CureVac GmbH. (10/3/13). "Press Release: CureVac to Collaborate with Janssen on Development of mRNA-based Influenza Vaccine". Tübingen. 2013-10-03
Zivak Technologies. (10/3/13). "Press Release: Introduction of SPE9600 Automated 96-Well-Plate SPE System at Medica 2013 Fair". 2013-10-03
Zivak Technologies. (10/2/13). "Press Release: ZinMass Clinical LC-MS/MS Analyzer Will Be Exhibited at Medica 2013". 2013-10-02
Acino Holding AG. (10/2/13). "Press Release: Avista Capital Partners and Nordic Capital to Launch a Joint Public Tencer Offer to Acquire Acino. Offer Price of CHF 115.00 Represents a 33% Premium to the Closing Share Price on October 1, 2013". Aesch. 2013-10-02
MorphoSys AG. (10/2/13). "Press Release: MorphoSys Collaborator to Start Pivotal Study with Bimagrumab. MorphoSys to Receive Clinical Milestone Payment". 2013-10-02
BASF SE. (10/2/13). "Press Release: BASF Commences Tender Offer to Verenium’s Shareholders. Offer Period from October 2 to October 31, 2013 – Cash Offer US$4.00 per Share". Ludwigshafen. 2013-10-02
BASF SE. (10/2/13). "Press Release: BASF Raises 2020 Sales Target for Its Crop Protection Division to €8 Billion. €1.8 Billion in Investments between 2013 and 2017 to Meet Growing Market Demand". Limburgerhof. 2013-10-02
Epigenomics AG. (10/2/13). "Press Release: Epigenomics Signs Joint Commercialization Agreement for Epi proColon in North America with Polymedco". Berlin. 2013-10-02
Bremen MS Seminar. (10/1/13). "Press Release: Bremen Mass Spectrometry Seminar Launches. First Talk by Prof. Pieter Dorrestein from the University of California – San Diego on 16th October". Bremen. 2013-10-01
Omnilab-Laborzentrum GmbH & Co. KG. (10/1/13). "Pressemitteilung: Omnilab expandiert national. Omnilab-Laborzentrum GmbH & Co. KG erweitert und bündelt Vertriebsstrukturen". 2013-10-01
EffRx Pharmaceuticals S.A.. (10/1/13). "Press Release: EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for PolyCystic Ovary Syndrome (PCOS) in Paediatric Populations". Freienbach. 2013-10-01
Definiens AG. (10/1/13). "Press Release: Personalized Medicine Roadmap. Definiens Releases Five Steps to Utilize Data Mining with Image Analysis". Munich & Carlsbad, CA. 2013-10-01
Amgen Inc.. (10/1/13). "Press Release: Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer. Acquisition Expected to Close Today – Deal Valued at $9.7 Billion". Thousand Oaks, CA. 2013-10-01
Activiomics Ltd.. (9/30/13). "Press Release: Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO". London. 2013-09-30
Dualsystems Biotech AG. (9/30/13). "Press Release: Dualsystems Biotech Closes Series C Financing Round". 2013-09-30
Evotec AG. (9/30/13). "Press Release: Evotec Receives Clinical Milestone as Part of Its Discovery Alliance with Boehringer Ingelheim". Hamburg. 2013-09-30
Analytik Jena AG. (9/30/13). "Pressemitteilung: Analytik Jena AG verlängert Verträge von Vorstandsvorsitzendem Klaus Berka und Finanzvorstand Stefan Döhmen. Gründer und Vorstand Jens Adomat verlässt das Unternehmen auf eigenen Wunsch". Jena. 2013-09-30
Ardian. (9/30/13). "Press Release: Axa Private Equity Becomes Ardian. A New Chapter Begins as an Independent Private Investment Company". Paris. 2013-09-30
Bayer AG. (9/30/13). "Press Release: Olivier Brandicourt Appointed as New CEO of Bayer HealthCare". Leverkusen. 2013-09-30
Isarna Therapeutics GmbH. (9/30/13). "Press Release: Antisense Pharma Changes Name to Isarna Therapeutics". Munich & Zurich. 2013-09-30
Bayer AG. (9/30/13). "Press Release: Bayer Submits Nexavar (sorafenib) for Marketing Authorization in Thyroid Cancer in Japan [Not intended for U.S. and UK Media]". Berlin. 2013-09-30
Mologen AG. (9/30/13). "Press Release: Final Analysis Confirmed Preliminary Results of Renal Cancer Vaccine MGN1601". 2013-09-30
Basilea Pharmaceutica Ltd.. (9/30/13). "Press Release: Basilea Reports Positive Topline Phase 3 Results for Antifungal Isavuconazole". Basel. 2013-09-30
Merck KGaA. (9/28/13). "Press Release: Merck’s Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-type Patients when Compared with Bevacizumab. New Analysis of FIRE-3 AIO Study". Darmstadt & Amsterdam. 2013-09-28
Biognosys AG. (9/27/13). "Press Release: New MRM Panel for Dried Blood Spot Samples". 2013-09-27
Endress+Hauser AG. (9/27/13). "Press Release: Endress+Hauser Prepares Offer for Analytik Jena. Swiss Measurement Technology Specialist Gains Control". 2013-09-27
M+W Group. (9/27/13). "Press Release: M+W Group Hands Over Most Advanced Research Laboratory to Nestlé". 2013-09-27
Glycotope GmbH. (9/27/13). "Press Release: Glycotope Presents Phase I Results of Novel Glycooptimized Monoclonal anti-TA-MUC1 Antibody PankoMAb-GEX at European Cancer Congress". Berlin. 2013-09-27
Ablynx N.V.. (9/26/13). "Press Release: Ablynx and Merck Serono further Strengthen Their Collaboration on Co-discovery and Co-development of Nanobodies. Creation of Dedicated Discovery Unit at Ablynx". Ghent. 2013-09-26
Berthold Technologies GmbH & Co. KG. (9/26/13). "Press Release: Berthold Technologies Launches Mithras2 Multi-technology Microplate Reader with Monochromators". Bad Wildbad. 2013-09-26
4SC AG. (9/26/13). "Press Release: 4SC Discovery and Panoptes Pharma Sign Patent Transfer Agreement for Novel Compound to Treat Severe Eye Diseases". Planegg-Martinsried & Vienna. 2013-09-26
Boehringer Ingelheim. (9/26/13). "Press Release: Boehringer Ingelheim Significantly Expands Its Production Footprint in China. Inauguration Ceremony for Zhangjiang Plant Expansion in Shanghai – Investment of 70 Million Euro". Shanghai & Ingelheim. 2013-09-26
Merck KGaA. (9/26/13). "Press Release: Merck Announces Further Management Changes to Drive Pharmaceutical Business Growth". Darmstadt. 2013-09-26
Panoptes Pharma GmbH. (9/26/13). "Press Release: Panoptes Pharma Successfully Closed Seed-financing Round of EUR 1.2 Million. Focus on Development of Small Molecule Drugs to Treat Severe Eye Diseases". Vienna. 2013-09-26
Cell Medica Ltd.. (9/26/13). "Press Release: Cell Medica Opens a Central European Manufacturing Facility in Berlin-Buch (Germany)". London. 2013-09-26
Merck KGaA. (9/25/13). "Press Release: Merck Announces Decision to Continue the Development of Tecemotide in Stage III Non-small Cell Lung Cancer". Darmstadt. 2013-09-25
Pacific Biosciences of California, Inc.. (9/25/13). "Press Release: Pacific Biosciences Announces Agreement with Roche Diagnostics to Develop and Supply DNA Sequencing-based Products for Clinical Diagnostics". Menlo Park, CA. 2013-09-25
Indivumed GmbH. (9/25/13). "Press Release: Indivumed Sells Inostics, the Plasma-DNA Company, to Sysmex and Expands Its Clinical Research Service and Patient Diagnostics Business". Hamburg. 2013-09-25
Boehringer Ingelheim. (9/25/13). "Press Release: Giotrif (afatinib) Approved in Europe for Patients with EGFR Mutation Positive Lung Cancer [For non U.S. Media Only]". Ingelheim. 2013-09-25
Mologen AG. (9/25/13). "Press Release: Mologen AG Submitted Clinical Trial Application (IND) for MGN1703 to the FDA". 2013-09-25
Bruker Corporation. (9/24/13). "Press Release: New minispec Sample Automation System for TD-NRM Applications Delivers Increased Productivity and Efficiency". Karlsruhe. 2013-09-24
Sysmex Corporation. (9/24/13). "Press Release: Sysmex Acquiring Two Germany Based Companies to Expand Its Technology Platform Targeting Personalized Medicine and Entering New Fields of Business". 2013-09-24
Nanion Technologies GmbH. (9/24/13). "Press Release: Nanion Starts Shipping the SyncroPatch 384 Patch Engine – a Revolutionary Instrument for Giga-seal, Automated Patch Clamb-based Ion Channel Drug Screening". Munich. 2013-09-24
Evogene Ltd.. (9/24/13). "Press Release: Evogene Files Registration Statement for Proposed Initial Public Offering in the United States". Rehovot. 2013-09-24
Myelo Therapeutics GmbH. (9/23/13). "Press Release: Myelo Therapeutics GmbH Closes Financing Round for Development of Adjuvant Cancer Therapy". Berlin. 2013-09-23
Formycon AG. (9/23/13). "Press Release: Formycon AG Moves Steadily Forward with Product Pipeline, Announces Half-year Results". Munich. 2013-09-23
Analytik Jena AG. (9/20/13). "Press Release: Analytik Jena AG Successfully Completes Capital Increase". Jena. 2013-09-20
BioOutsource Ltd.. (9/20/13). "Press Release: BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterization and Comparability Testing". Boston, MA & Glasgow. 2013-09-20
BASF SE. (9/20/13). "Press Release: BASF Announces Cash Offer to Acquire Specialized Enzyme Biotechnology Company Verenium. Cash Offer US$4.00 per Share". Ludwigshafen. 2013-09-20
Actelion Ltd.. (9/19/13). "Press Release: Actelion Closes Acquisition of Privately-held Ceptaris Therapeutics Adding Valchlor to Actelion’s Product Portfolio. Valchlor Is the Only FDA-approved Topical Formulation of Mechlorethamine". Allschwil. 2013-09-19
Analytik Jena AG. (9/19/13). "Pressemitteilung: Veröffentlichung gem. § 26 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung [Endress+Hauser hält nun 22,33% Stimmrechtsanteil]". 2013-09-19
MorphoSys AG. (9/19/13). "Press Release: MorphoSys Raises EUR 84 Million in Private Placement". 2013-09-19
Exosome Diagnostics, Inc.. (9/19/13). "Press Release: Exosome Diagnostics Enters Collaboration with Lilly for Exosome Blood-based Biomarker Discovery". New York, NY. 2013-09-19
bm-t Beteiligungsmanagement Thüringen GmbH. (9/18/13). "Press Release: Udo Werner Named New CEO of bm-t". 2013-09-18
IKFE Services GmbH. (9/18/13). "Pressemitteilung: Die neue IKFE Services GmbH. Columbia Healthcare Serivces, Inc. gründet deutsches Unternehmen in Mainz". 2013-09-18
BioGenes GmbH. (9/18/13). "Press Release: BioGenes Launches Enhanced Generic HCP Assay for Early Stage Biologics Production". Berlin. 2013-09-18
MorphoSys AG. (9/18/13). "Press Release: MorphoSys to Raise Capital via a Private Placement of New Shares". 2013-09-18
Definiens AG. (9/18/13). "Press Release: Christiaan Neeleman Appointed COO of Definiens". Munich. 2013-09-18
Addex Therapeutics S.A.. (9/17/13). "Press Release: Addex Therapeutics First Half 2013 Financial Results". Geneva. 2013-09-17
Genedata AG. (9/17/13). "Press Release: Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform". Basel. 2013-09-17
High-Tech Gründerfonds Management GmbH. (9/17/13). "Press Release: Microstim Successfully Raised Funds for the First Clinical Application of Their Heart Assist System". Bonn & Wismar. 2013-09-17
MorphoSys AG. (9/17/13). "Press Release: MorphoSys Receives Two Phase 2 Milestone Payments from Janssen". 2013-09-17
Sartorius AG. (9/17/13). "Press Release: Sartorius Stedim Biotech and Alfa Laval Extend Their Partnership". Göttingen. 2013-09-17
Affimed Therapeutics AG. (9/16/13). "Press Release: Affimed Therapeutics and The Leukemia & Lymphoma Society Partner to Advance AFM13 in a Phase 2 Trial for Refractory and/or Relapsed Hodgkin Lymphoma Patients". Heidelberg & Whie Plains, NY. 2013-09-16
Bruker Corporation. (9/16/13). "Press Release: Bruker Announces Second-phase Collaboration Agreement with Siscapa Assay Technologies for Further Development and Commercialization of SISCAPA-MALDI Assays". Yokohama. 2013-09-16
Bruker Corporation. (9/16/13). "Press Release: Bruker Introduces maXis HD Ultra-high Resolution QTOF at HUPO". Yokohama. 2013-09-16
Roche. (9/16/13). "Press Release: Christoph Franz Nominated to Become New Roche Chairman". Basel. 2013-09-16
Fresenius SE & Co. KGaA. (9/13/13). "Press Release: Fresenius Helios Acquires 43 Hospitals from Rhön-Klinikum AG". Bad Homburg v. d. H.. 2013-09-13
Bruker Corporation. (9/12/13). "Press Release: Bruker Announces Acquisition of Prairie Technologies". Billerica, MA. 2013-09-12
Evotec AG. (9/12/13). "Press Release: Evotec and Harvard Stem Cell Institute Form CureMN Collaboration to Advance ALS Research". Hamburg. 2013-09-12
Jacobs University Bremen. (9/12/13). "Press Release: Phytolutions and OceanLab Install First Outdoor Microalgae Plant in Chinese City of Weihai". 2013-09-12
Nanion Technologies GmbH. (9/12/13). "Press Release: Nanion Introduces New Product Family. CardioExcyte 96 for Cardiac Toxicity Profiling and Screening". Munich. 2013-09-12
next pagenext page 1 2 3 ... 54 55 56 ... 97 98 99  next pagenext page


Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSUS] – The Business Web Portal 600x60px

» top